Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps

Sari K., Gencer Z. K., Ede H., GÖÇMEN A. Y., Kantekin Y.

AURIS NASUS LARYNX, vol.43, no.5, pp.529-536, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 5
  • Publication Date: 2016
  • Doi Number: 10.1016/j.anl.2015.12.009
  • Journal Name: AURIS NASUS LARYNX
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.529-536
  • Yozgat Bozok University Affiliated: Yes

Abstract

Objective: Nasal polyps (NP) are a chronic inflammatory disease of the nasal mucosa; their etiology is suspected to involve oxidative stress. Growth differentiation factor-15 (GDF-15), brain natriuretic peptide (BNP), and ischemia-modified albumin (IMA) are biomarkers used especially in the early diagnosis and follow-up of cardiovascular diseases. The aim of this study was to assess levels of serum GDF-15, BNP, and IMA in patients with NP and to compare them with those of healthy subjects.